Bio Protocol has introduced BioAgents and an AI intelligence layer called Gaia to automate and enhance decentralized science operations in biotech research. These AI agents help with hypothesis generation, literature analysis, governance, and community coordination, running on various platforms and hardware. Gaia adds accountability by scoring agent performance across six dimensions, while OpenLabs foster collaboration between humans and AI to turn ideas into funded projects. Supported by $6.9 million in funding and partnerships with VitaDAO and Molecule, Bio Protocol aims to streamline and scale tokenized biotech research using its BIO token ecosystem.
Bio Protocol has introduced OpenLabs, a platform that connects scientific researchers and AI agents with a USDC-based revenue model to fund decentralized science projects. This approach replaces traditional grant funding with stablecoin payments, off...
Streamex has introduced GLDY, a tokenized gold security designed to be held in traditional brokerage accounts, making gold investment more accessible without needing crypto wallets. Classified as a security under SEC Rule 506(c), GLDY targets accredi...
